Pneumococcal vaccine in patients with absent or dysfunctional spleen

Mayo Clinic Proceedings

Volumn 75, Issue 7, 2000, Pages 749-753

  Kobel, Dominique Eve ^a   Friedl, Andrée ^b   Cerny, Thomas ^c   Mühlemann, Kathrin ^a   Cerny, Andreas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Medical Clinic C   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HODGKIN DISEASE; HUMAN; MALE; SPLEEN DISEASE; SPLENECTOMY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION; WHOLE BODY RADIATION;

EID: 0033949352     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.7.749     Document Type: Article

References (35)

1. Paul WE, ed. Fundamental Immunology. 3rd ed. New York, NY: Raven Press; 1993.
2. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA. 1993;270:1826-1831.
3. Kinnersley P, Wilkinson CE, Srinivasan J. Pneumococcal vaccination after splenectomy: survey of hospital and primary care records. BMJ. 1993;307:1398-1399.
4. Klein RS, Adachi N. An effective hospital-based pneumococcal immunization program. Arch Intern Med. 1986;146:327-329.
5. Centers for Disease Control and Prevention. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of working group. MMWR Morb Mortal Wkly Rep. 1996;45(RR-1):1-20
6. Edwards LD, Digioia R. Infections in splenectomized patients: a study of 131 patients. Scand J Infect Dis. 1976;8:255-261.
7. Fielding AK. Prophylaxis against late infection following splenectomy and bone marrow transplant. Blood Rev. 1994;8:179-191.
8. Jockovich M, Mendenhall NP, Sombeck MD, Talbert JL, Copeland EM III, Bland KI. Long-term complications of laparotomy in Hodgkin's disease. Ann Surg. 1994;219:615-621.
9. Notier DT, Grossman PL, Rosenberg SA, Remington JS. Infections in patients with Hodgkin's disease: a clinical study of 300 consecutive adult patients. Rev Infect Dis. 1980;2:761-800.
10. Obaro SK, Monteil MA, Henderson DC. The pneumococcal problem. BMJ. 1996;312:1521-1525,
11. Keel A, Bennett B, Sarkar TK, Forman KM, Dawson AA, Jones PF. Splenectomy and infection in Hodgkin's disease. Br J Surg. 1983;70:278-280.
12. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ. 1996;312:430-434.
13. Rege K, Mehta J, Treleaven J, et al. Fatal pneumococcal infections following allogeneic bone marrow transplant. Bone Marrow Transplant. 1994;14:903-906.
14. Chilcote RR, Baehner RL, Hammond D. Septicemia and meningitis in children splenectomized for Hodgkin's disease. N Engl J Med. 1976;295:798-800.
15. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg. 1991;78:1031-1038.
16. Shaw JH, Print CG. Postsplenectomy sepsis. Br J Surg. 1989;76: 1074-1081.
17. Donaldson SS, Glatstein E, Vosti KL. Bacterial infections in pediatrie Hodgkin's disease: relationship to radiotherapy, chemotherapy and splenectomy. Cancer. 1978;41:1949-1958.
18. Aavitsland P, Froholm LO, Hoiby EA, Lystad A. Risk of pneumococcal disease in individuals without a spleen [letter]. Lancet. 1994; 344:1504.
19. Ljungman P, Cordonnier C, de Bock R, et al, Infectious Diseases Working Party of the EBMT. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1995; 15:455-460.
20. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991 ;325:1453-1460.
21. Wust J, Huf E, Kayser FH. Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland. J Clin Microbiol. 1995;33:3159-3163.
22. Hosea SW, Burch CG, Brown EJ, Berg RA, Frank MM. Impaired immune response of splenectomised patients of polyvalent pneumococcal vaccine. Lancet. 1981;1:804-807.
23. Siber GR, Weitzman SA, Aisenberg AC, Weinstein HJ, Schiffman G. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med. 1978;299:442-448.
24. Siber GR, Gorham C, Martin P, Corkery JC, Schiffman G. Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease. Ann Intern Med. 1986; 104:467-475.
25. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Morb Mortal Wkly Rep. 1993 ;42(RR-4):1-18.
26. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46(RR-8):1-24.
27. Centers for Disease Control and Prevention. Update: pneumococcal polysaccharide vaccine usage - United States. MMWR Morb Mortal Wkly Rep. 1984;33:273-276, 281.
28. Jackson LA, Benson P, Sneller VP, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA. 1999;281:243-248.
29. Ridgway D, Wolff LJ. Active immunization of children with leukemia and other malignancies. Leuk Lymphoma. 1993;9:177-192.
30. Carey I, Glauser MP, Bille J. Pneumococcal bacteremia: what is new? [in French]. Schweiz Med Wochenschr. 1995;125:952-958.
31. Fedson DS. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. Clin Infect Dis. 1998;26: 1117-1123.
32. Watson DA, Musher DM, Jacobson JW, Verhoef J. A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis. 1993;17:913-924.
33. Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr. 1996; 128:649-653.
34. Chan CY, Molrine DC, George S, et al. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J Infect Dis. 1996;173:256-258.
35. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. / Infect Dis. 1996;174:1271-1278.